Compared to the folate conjugate core-shell NPs developed earlier by our group [5], we observed nearly 25 times higher NP internalization into A549 cancer cells when conjugating antibodies against EphA2 onto the NP surfaces. The gene discussed is EPHA2; the disease is cancer.